These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1719206)

  • 1. Neutralization epitope in the envelope glycoprotein of simian retrovirus-1 (SRV-1) and identification of the virus receptor.
    Torres JV; Werner LL; Malley A; Benjamin E
    J Med Primatol; 1991 Jun; 20(4):218-21. PubMed ID: 1719206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of T- and B-cell epitopes of a simian retrovirus (SRV-2) envelope protein.
    Malley A; Werner L; Benjamini E; Leung CY; Torres J; Pangares N; Shiigi S; Axthelm M
    J Med Primatol; 1991 Jun; 20(4):177-81. PubMed ID: 1719205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of the neutralizable epitope of simian retrovirus-1 (SRV-1) and of the cell receptor for the virus.
    Benjamini E; Torres JV; Werner LL; Malley A
    Adv Exp Med Biol; 1991; 303():71-7. PubMed ID: 1725239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunobiological properties of a recombinant simian retrovirus-1 envelope protein and a neutralizing monoclonal antibody directed against it.
    Werner LL; Torres JV; Leung CY; Kwang HS; Malley A; Benjamini E
    Mol Immunol; 1991 Aug; 28(8):819-26. PubMed ID: 1715026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of T cell epitopes on the envelope glycoprotein of simian retrovirus 1 and 2 (SRV-1 and SRV-2) in several mouse strains.
    Malley A; Torres JV; Benjamini E; Pangares N; Axthelm M
    Mol Immunol; 1992; 29(7-8):999-1004. PubMed ID: 1378937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The induction of neutralizing antibodies by synthetic peptides of the envelope protein of type D simian retrovirus-1 (SRV-1).
    Torres JV; Werner LL; Malley A; Benjamini E
    Mol Immunol; 1991 Aug; 28(8):907-13. PubMed ID: 1652065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies to type D retrovirus (SRV-2).
    Tsai CC; Tsai CC; Sligh JM; Yarnall M; Follis KE; Roodman ST
    J Med Primatol; 1989; 18(3-4):175-83. PubMed ID: 2547955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simian retrovirus receptor and neutralization mechanism by antibodies to the envelope glycoprotein.
    Anderson DE; Torres JV
    Viral Immunol; 1999; 12(1):47-56. PubMed ID: 10333242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of infectious type D retrovirus from baboons.
    Grant RF; Windsor SK; Malinak CJ; Bartz CR; Sabo A; Benveniste RE; Tsai CC
    Virology; 1995 Feb; 207(1):292-6. PubMed ID: 7871741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic peptides of envelope proteins of two different strains of simian AIDS retrovirus (SRV-1 and SRV-2) represent unique antigenic determinants for serum neutralizing antibodies.
    Werner LL; Malley A; Torres JV; Leung CY; Kwang HS; Benjamini E
    Mol Immunol; 1990 Nov; 27(11):1103-11. PubMed ID: 1701027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIV envelope glycoprotein epitopes recognized by antibodies from infected or vaccinated rhesus macaques.
    Torres JV; Anderson DE; Malley A; Banapour B; Axthelm MK; Benjamini E; Gardner MB
    J Med Primatol; 1993; 22(2-3):129-37. PubMed ID: 7692056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional epitopes on porcine endogenous retrovirus envelope protein interacting with neutralizing antibody combining sites.
    Chiang CY; Pan YR; Chou LF; Fang CY; Wang SR; Yang CY; Chang HY
    Virology; 2007 May; 361(2):364-71. PubMed ID: 17222436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of macaques against infection with simian type D retrovirus (SRV-1) by immunization with recombinant vaccinia virus expressing the envelope glycoproteins of either SRV-1 or Mason-Pfizer monkey virus (SRV-3).
    Brody BA; Hunter E; Kluge JD; Lasarow R; Gardner M; Marx PA
    J Virol; 1992 Jun; 66(6):3950-4. PubMed ID: 1316495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
    Ahlers JD; Pendleton CD; Dunlop N; Minassian A; Nara PL; Berzofsky JA
    J Immunol; 1993 Jun; 150(12):5647-65. PubMed ID: 8515081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus.
    Balasuriya UB; Maclachlan NJ; De Vries AA; Rossitto PV; Rottier PJ
    Virology; 1995 Mar; 207(2):518-27. PubMed ID: 7533965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus.
    Plagemann PG
    Vet Immunol Immunopathol; 2004 Dec; 102(3):263-75. PubMed ID: 15507310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein.
    Balasuriya UB; Patton JF; Rossitto PV; Timoney PJ; McCollum WH; MacLachlan NJ
    Virology; 1997 May; 232(1):114-28. PubMed ID: 9185595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT; Bolin RA; Kelly RG
    Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a synthetic envelope peptide of SRV-1 and SRV-2 virus that specifically binds rhesus anti-SRV-1 and anti-SRV-2 neutralizing antibodies.
    Malley A; Shiigi S; Benjamini E; Werner L; Leung CY; Kwang HS; Axthelm M; Hallick LM
    Adv Exp Med Biol; 1989; 251():169-73. PubMed ID: 2481957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.